Cited by 629Treatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 198 of the 203 references it cites were found in a registry or an index.

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

Vaswani, Meera, Linda, Farzana Kadar, Ramesh, Subramanyam·2003·Progress in Neuro-Psychopharmacology and Biological Psychiatry

DOI 10.1016/s0278-5846(02)00338-x

Open this paper in CoChat — free account

Abstract

The selective serotonin reuptake inhibitors (SSRIs) have emerged as a major therapeutic advance in psychopharmacology. As a result, the discovery of these agents marks a milestone in neuropsychopharmacology and rational drug design, and has launched a new era in psychotropic drug development. Prior to the SSRIs, all psychotropic medications were the result of chance observation. In an attempt to develop a SSRI, researchers discovered a number of nontricyclic agents with amine-uptake inhibitory properties, acting on both noradrenergic and serotonergic neurons with considerable differences in potency. A given drug may affect one or more sites over its clinically relevant dosing range and may produce multiple and different clinical effects. The enhanced safety profile includes a reduced likelihood of pharmacodynamically mediated adverse drug-drug interactions by avoiding affects on sites that are not essential to the intended outcome. SSRIs were developed for inhibition of the neuronal uptake pump for serotonin (5-HT), a property shared with the TCAs, but without affecting the other various neuroreceptors or fast sodium channels. The therapeutic mechanism of action of SSRIs involves alteration in the 5-HT system. The plethora of biological substrates, receptors and pathways for 5-HT are candidates to mediate not only the therapeutic actions of SSRIs, but also their side effects. A hypothesis to explain these immediate side effects is that 5-HT is increased at specific 5-HT receptor subtypes in discrete regions of the body where the relevant physiologic processes are regulated. Marked differences exist between the SSRIs with regard to effects on specific cytochrome P450 (CYP) enzymes, and thus the likelihood of clinically important pharmacokinetic drug-drug interactions. Although no clear relationship exists between the clinical efficacy, plasma concentration of SSRIs, nor any threshold that defines toxic concentrations, but therapeutic drug monitoring (TDM) may be useful in special populations, such as in elderly patients, poor metabolizers (PM) of sparteine (CYP2D6) or mephenytoin (CYP2C19), and patients with liver and kidney impairment. Several meta-analyses have reviewed the comparative efficacy of TCAs and SSRIs, and concluded that both TCAs and SSRIs have similar efficacy in the treatment of depression. SSRIs have demonstrated better efficacy and tolerability in the treatment of obsessive compulsive disorder (OCD). They have also been found to be effective in the treatment for social anxiety disorder both in reducing total levels of social anxiety and in improving overall clinical condition. The benefit of SSRIs in anorexia nervosa (AN) is apparently short-term unless medication is given in the context of nutritional or behavioral therapy. No single antidepressant can ever be recommended for every patient, but in a vast majority of patients, SSRIs should be considered as one of the first-line drugs in the treatment of depression.

Integrity signals

Registry

Crossref · 10.1016/s0278-5846(02)00338-x

Cites

198 of 198 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression
Geddes, J. R., Freemantle, N., Mason, J. M., Eccles, M., & Boynton, J. R. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001851 · Cited by 109
Retracted
Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results From the National Comorbidity Survey
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
The serotonin syndrome
Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 887
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 827
Birth Outcomes in Pregnant Women Taking Fluoxetine
Chambers, C., Johnson, K. A., Dick, L. M., Felix, R. J., & Jones, K. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351402 · Cited by 735
Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676

Show all 203 references

Research works printed but not linked: 6

Bauman, 1995, The pharmacokinetics of citalopram, Rev. Contemp. Pharmacother., 6, 287
Geddes, 2000, SSRIs versus other antidepressants for depressive disorder, Cochrane Database Syst. Rev., 2
Mendels, 1995, Sertraline, vol. 2, 2073
Preskorn, 1991, Therapeutic drug monitoring for antidepressants: efficacy, safety and cost effectiveness, J. Clin. Psychiatry, 52, 23
Spigset, 1997, Non-linear fluvoxamine disposition and relation to some CYP activities, Eur. J. Clin. Pharmacol., 52, A172
van der Kolk, 1994, Fluoxetine in posttraumatic stress disorder, J. Clin. Psychiatry, 55, 517

Sorted by citations

Items 201–300 of 629

Family‐based association study of TPH1 and TPH2 polymorphisms in autism
Ramoz, N., Cai, G., Reichert, J. G., Corwin, T. E., Kryzak, L. A., Smith, C. J., Silverman, J. M., Hollander, E., & Buxbaum, J. D. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30356 · Cited by 35
Fractures in the framework: limitations of classification systems inpsychiatry
Kapadia, M., Desai, M., & Parikh, R. M. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.1/rparikh · Cited by 40
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. part 3
Herold, F., Chodkowski, A., Izbicki, Ł., Turło, J., Dawidowski, M., Kleps, J., Nowak, G., Stachowicz, K., Dybała, M., Siwek, A., et al. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.10.026 · Cited by 34
Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins
Sayed, R. H., Saad, M. A., & El-Sahar, A. E. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.09.024 · Cited by 34
Effects of acute and chronic treatment with fluoxetine on stress-induced hyperthermia in telemetered rats and mice
Conley, R. K., & Hutson, P. H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.063 · Cited by 34
Perinatal Depression
Dossett, E. C. (2008) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2008.04.004 · Cited by 37
Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics
Kane, J. M., Conley, R. R., Keith, S. J., Nasrallah, H. A., & Turner, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0121 · Cited by 33
An analysis of the high psychotropic off-label use in psychiatric disorders
Devulapalli, K. K., & Nasrallah, H. A. (2009) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2009.01.005 · Cited by 33
Perifornical Hypothalamic Orexin and Serotonin Modulate the Counterregulatory Response to Hypoglycemic and Glucoprivic Stimuli
Otlivanchik, O., Foll, C. L., & Levin, B. E. (2014) · Diabetes · doi:10.2337/db14-0671 · Cited by 32
Anxiolytic-like effect of milnacipran in the four-plate test in mice: Mechanism of action
BOURIN, M., MASSE, F., DAILLY, E., & HASCOET, M. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.04.015 · Cited by 33
Reboxetine Versus Fluvoxamine in the Treatment of Motor Vehicle Accident-related Posttraumatic Stress Disorder
Spivak, B., Strous, R. D., Shaked, G., Shabash, E., Kotler, M., & Weizman, A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203195.65710.f0 · Cited by 33
Shared genetic architecture across psychiatric disorders
Grotzinger, A. D. (2021) · Psychological Medicine · doi:10.1017/s0033291721000829 · Cited by 40
Pharmacokinetics of Fluoxetine in Rhesus Macaques following Multiple Routes of Administration
Sawyer, E. K., & Howell, L. L. (2011) · Pharmacology · doi:10.1159/000329417 · Cited by 32
Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra
MacGillivray, L., Reynolds, K. B., Sickand, M., Rosebush, P. I., & Mazurek, M. F. (2011) · Synapse · doi:10.1002/syn.20954 · Cited by 32
Toxicology in the ICU
Brooks, D. E., Levine, M., O’Connor, A. D., French, R. N. E., & Curry, S. C. (2011) · CHEST Journal · doi:10.1378/chest.10-2726 · Cited by 32
Techniques for in vivo serotonin detection in the brain: State of the art
Zhao, S., & Piatkevich, K. D. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15865 · Cited by 33
Proteomic analysis of rat cortical neurons after fluoxetine treatment
Cecconi, D., Mion, S., Astner, H., Domenici, E., Righetti, P. G., & Carboni, L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.008 · Cited by 31
AZD6280, a Novel Partial γ-Aminobutyric Acid A Receptor Modulator, Demonstrates a Pharmacodynamically Selective Effect Profile in Healthy Male Volunteers
Chen, X., Jacobs, G. E., de Kam, M. L., Jaeger, J., Lappalainen, J., Maruff, P. T., Smith, M. A., Cross, A. J., Cohen, A. F., & van Gerven, J. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000251 · Cited by 30
6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors
Bromidge, S. M., Bertani, B., Borriello, M., Faedo, S., Gordon, L. J., Granci, E., Hill, M., Marshall, H. R., Stasi, L. P., Zucchelli, V., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.084 · Cited by 30
5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats
Salchner, P., & Singewald, N. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0247-5 · Cited by 32
Pharmacotherapy of Depressed Children and Adolescents: Current Issues and Potential Directions
Vasa, R. A., Carlino, A. R., & Pine, D. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.010 · Cited by 29
Integrated 16S rDNA, metabolomics, and TNF-α/NF-κB signaling pathway analyses to explain the modulatory effect of Poria cocos aqueous extract on anxiety-like behavior
Zhang, D., Li, H., Luo, X., Liu, D., Wei, Q., & Ye, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154300 · Cited by 29
Production of chiral compound using recombinant Escherichia coli cells co-expressing reductase and glucose dehydrogenase in an ionic liquid/water two phase system
Choi, H. J., Uhm, K.-N., & Kim, H. K. (2011) · Journal of Molecular Catalysis B Enzymatic · doi:10.1016/j.molcatb.2011.02.013 · Cited by 29
Trauma, Adaptation, and Resilience: A Cross-Cultural and Evolutionary Perspective
Konner, M. J. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511500008.021 · Cited by 30
Serotonergic perturbations in dystonia disorders—a systematic review
Smit, M., Bartels, A. L., van Faassen, M. H. J. R., Kuiper, A., Niezen‐Koning, K. E., Kema, I. P., Dierckx, R., de Koning, T. J., & Tijssen, M. A. J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.015 · Cited by 29
Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach
Sreeja, V., Jose, A., Patel, S., Menon, B., Athira, K. V., & Chakravarty, S. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105672 · Cited by 30
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Alexander, C., Jeon, J., Nickerson, K., Hassler, S. N., & Vasefi, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116742 · Cited by 28
The safety of antidepressant use in pregnancy
Kalra, S., Born, L., Sarkar, M., & Einarson, A. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.2.273 · Cited by 28
Neuroimaging of the Serotonin Transporter: Possibilities and Pitfalls
Brust, P., Hesse, S., Müller, U., & Szabó, Z. R. (2005) · Current Psychiatry Reviews · doi:10.2174/157340006775101508 · Cited by 29
Diphenyl diselenide elicits antidepressant-like activity in rats exposed to monosodium glutamate: A contribution of serotonin uptake and Na+, K+-ATPase activity
Quines, C. B., Rosa, S. G., Velasquez, D., da Rocha, J. T., Neto, J. S. S., & Nogueira, C. W. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.038 · Cited by 28
Single-Shot Detection of Neurotransmitters in Whole-Blood Samples by Means of the Heat-Transfer Method in Combination with Synthetic Receptors
Vandenryt, T., van Grinsven, B., Eersels, K., Cornelis, P., Kholwadia, S., Cleij, T. J., Thoelen, R., Ceuninck, W. D., Peeters, M., & Wagner, P. (2017) · Sensors · doi:10.3390/s17122701 · Cited by 30
Asymmetric synthesis of (S)-3-chloro-1-phenyl-1-propanol using Saccharomyces cerevisiae reductase with high enantioselectivity
Choi, Y., Choi, H. J., Kim, D., Uhm, K.-N., & Kim, H. K. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2442-5 · Cited by 27
Exploring Endocytosis and Intracellular Trafficking of the Human Serotonin1A Receptor
Kumar, G. A., Sarkar, P., Jafurulla, M., Singh, S. P., Srinivas, G., Pande, G., & Chattopadhyay, A. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00033 · Cited by 28
Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
de Filippis, R., Mercurio, M., Spina, G., Fazio, P. D., Segura‐Garcìa, C., Familiari, F., Gasparini, G., & Galasso, O. (2022) · Healthcare · doi:10.3390/healthcare10050803 · Cited by 31
Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations
Sethi, P., Mehan, S., Khan, Z., & Chhabra, S. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.08.001 · Cited by 28
Effect of Xiaoyaosan on major depressive disorder
Jing, L., Zhu, X., Lv, Z., & Sun, X. (2015) · Chinese Medicine · doi:10.1186/s13020-015-0050-0 · Cited by 27
Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity
MacGillivray, L., Lagrou, L. M., Reynolds, K. B., Rosebush, P. I., & Mazurek, M. F. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.055 · Cited by 29
Selective Influence on Contextual Memory: Physiochemical Properties Associated with Selectivity of Benzodiazepine Ligands at GABAAReceptors Containing the α5 Subunit
Harris, D. L., Clayton, T., Cook, J. M., Sahbaie, P., Halliwell, R. F., Furtmüller, R., Huck, S., Sieghart, W., & DeLorey, T. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701433b · Cited by 27
Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project
The EPOS Group, Salokangas, R. K. R., Schultze‐Lutter, F., Hietala, J. A., Heinimaa, M., From, T., Ilonen, T., Löyttyniemi, E., von Reventlow, H. G., Juckel, G., et al. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1160-9 · Cited by 27
Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment
Liu, W., Wang, H., Li, X., Xu, Y., Zhang, J., Wang, W., Gong, Q., Qiu, X., Zhu, J., Mao, F., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.037 · Cited by 27
Acupuncture for Psychological Disorders Caused by Chronic Pain: A Review and Future Directions
Lin, L., Li, H., Yang, J., Hao, X.-W., Yan, S., Wang, Y., Yu, F.-T., Shi, G., & Liu, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.626497 · Cited by 27
Developmental Exposure to Fluoxetine Modulates the Serotonin System in Hypothalamus
Berg, C., Bäckström, T., Winberg, S., Lindberg, R. H., & Brandt, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055053 · Cited by 26
Anxiolytic profile of fluoxetine as monitored following repeated administration in animal rat model of chronic mild stress
Farhan, M., & Haleem, D. J. (2015) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2015.03.006 · Cited by 28
Management strategies in SSRI-associated sexual dysfunction in women at midlife
Fooladi, E., Bell, R. J., & Davis, S. R. (2012) · Climacteric · doi:10.3109/13697137.2012.658461 · Cited by 26
Neonatal lipopolysaccharide treatment has long‐term effects on monoaminergic and cannabinoid receptors in the rat
Zavitsanou, K., Dalton, V. S., Walker, A. K., Weickert, C. S., Sominsky, L., & Hodgson, D. M. (2013) · Synapse · doi:10.1002/syn.21640 · Cited by 26
Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs)
Schmitz, W. D., Denhart, D. J., Brenner, A. B., Ditta, J. L., Mattson, R. J., Mattson, G. K., Molski, T. F. P., & Macor, J. E. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.059 · Cited by 26
The Use of a Cholinesterase Inhibitor Review Committee in Long-Term Care
Lee, J., Monette, J., Sourial, N., Monette, M., & Bergman, H. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.02.007 · Cited by 26
Psychiatric services in primary care settings: a survey of general practitioners in Thailand
Lotrakul, M., & Saipanish, R. (2006) · BMC Family Practice · doi:10.1186/1471-2296-7-48 · Cited by 25
Use of polypharmacotherapy in pregnancy: a prospective outcome in a case
Yarış, F., Yariş, E., Kadıoğlu, M., Ulku, C., Kesim, M., & Kalyoncu, N. İ. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.010 · Cited by 25
Psychotropic drugs in pregnancy: a case-control study
Yarış, F., Ulku, C., Kesim, M., Kadıoğlu, M., Unsal, M. A., Dikici, M. F., Kalyoncu, N. İ., & Yariş, E. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.020 · Cited by 25
Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress
Dazzi, L., Seu, E., Cherchi, G., & Biggio, G. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.11.003 · Cited by 25
Machine learning prediction of anxiety symptoms in social anxiety disorder: utilizing multimodal data from virtual reality sessions
Park, J.-H., Shin, Y.-B., Jung, D., Hur, J., Pack, S. P., Lee, H.-J., Lee, H., & Cho, C. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1504190 · Cited by 32
Baiap3 regulates depressive behaviors in mice via attenuating dense core vesicle trafficking in subsets of prefrontal cortex neurons
Kim, H., Kim, J., Lee, H., Shin, E., Kang, H., Jeon, J., & Youn, B. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100423 · Cited by 24
Differential effects of NMDA receptor antagonism on spine density
Ruddy, R. M., Chen, Y., Milenkovic, M., & Ramsey, A. J. (2014) · Synapse · doi:10.1002/syn.21784 · Cited by 23
HPLC Method for Chiral Separation and Quantification of Antidepressant Citalopram and Its Precursor Citadiol
Geryk, R., Vozka, J., Kalíková, K., & Tesařová, E. (2013) · Chromatographia · doi:10.1007/s10337-013-2426-6 · Cited by 24
Fluoxetine Reduces Murine Graft-Versus-Host Disease by Induction of T cell Immunosuppression
Gobin, V., Steendam, K. V., Fevery, S., Tilleman, K., Billiau, A., Denys, D. A. J. P., & Deforce, D. L. D. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9463-7 · Cited by 24
Ethological computational psychiatry: Challenges and opportunities
Monosov, I. E., Zimmermann, J., Frank, M. J., Mathis, M. W., & Baker, J. T. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102881 · Cited by 21
Antidepressant-Like Effect of Chronic Taurine Administration and Its Hippocampal Signal Transduction in Rats
Toyoda, A., & Iio, W. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6130-2_3 · Cited by 24
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States
Esposito, D., Wahl, P. M., Daniel, G. W., Stoto, . A., Erder, M. H., & Croghan, T. W. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.03.012 · Cited by 23
Molecular Mechanisms of Cannabis Signaling in the Brain
Ronan, P. J., Wongngamnit, N., & Beresford, T. P. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.002 · Cited by 25
Behavioral and pharmacological phenotypes of brain-specific diacylglycerol kinase δ-knockout mice
Usuki, T., Takato, T., Lu, Q., Sakai, H., Bando, K., Kiyonari, H., & Sakane, F. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.017 · Cited by 23
Effects of Selective Serotonin Reuptake Inhibitors on Macular Ganglion Cell Complex Thickness and Peripapillary Retinal Nerve Fiber Layer Thickness
Güçlü, H., Görgülü, Y., Gürlü, V., Çınar, R. K., Özal, S. A., & Çalıyurt, O. (2017) · Current Eye Research · doi:10.1080/02713683.2017.1420198 · Cited by 23
Fluoxetine-induced anxiety and nervousness.
Zienowicz, M., Wisłowska-Stanek, A., Lehner, M., Taracha, E., Maciejak, P., Sobolewska, A., Szyndler, J., Turzyńska, D., Walkowiak, J., & Płaźnik, A. (2006) · PubMed · Cited by 23
The four-plates test–retest paradigm to discriminate anxiolytic effects
Ripoll, N., Dhonnchadha, B. Á. N., Sebille, V., Bourin, M., & Hascoët, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2130-1 · Cited by 23
The effect of short moderate stress on the midbrain corticotropin-releasing factor system in a macaque model of functional hypothalamic amenorrhea
Bethea, C. L., Phu, K., Reddy, A. P., & Cameron, J. L. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.052 · Cited by 23
The postnatal 5-HT1A receptor regulates adult anxiety and depression differently via multiple molecules
Ishikawa, C., & Shiga, T. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.014 · Cited by 23
Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain
Hirano, K., Seki, T., Sakai, N., Kato, Y., Hashimoto, H., Uchida, S., & Yamada, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.038 · Cited by 22
The role of duloxetine in the treatment of anxiety disorders
Berardis, D. D. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2546 · Cited by 21
Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis
Johnson, C. F. A., Maxwell, M., Williams, B., Dougall, N. J., & MacGillivray, S. A. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2021-000017 · Cited by 30
The Role of Fluorine in the Discovery and Optimization of CNS Agents
Hodgetts, K. J., Combs, K. J., Elder, A. M., & Harriman, G. C. B. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45026-5 · Cited by 21
Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003–2009
Aguglia, E., Ravasio, R., Simonetti, M., Pecchioli, S., & Mazzoleni, F. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.713341 · Cited by 23
Human Teratogens: Current Controversies
Frías, J. L., & Gilbert‐Barness, E. (2008) · Advances in Pediatrics · doi:10.1016/j.yapd.2008.07.005 · Cited by 21
Status epilepticus following intentional overdose of fluvoxamine: A case report with serum fluvoxamine concentration
Wood, D. M., Rajalingam, Y., Greene, S. L., Morgan, P. E., Gerrie, D., Jones, A. L., & Dargan, P. I. (2007) · Clinical Toxicology · doi:10.1080/15563650701664574 · Cited by 21
Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine
Harkin, A., Shanahan, E., Kelly, J. P., & Connor, T. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02802.x · Cited by 21
Investigation on the binding activities of citalopram with human and bovine serum albumins
Lin, J., Liu, Y., Chen, M., Huang, H., & Song, L. (2013) · Journal of Luminescence · doi:10.1016/j.jlumin.2013.09.054 · Cited by 21
Methodological Issues in Conducting Treatment Trials for Psychological Nonepileptic Seizures
LaFrance, W. C., Jr., Blum, A. S., Miller, I. W., Ryan, C. E., & Keitner, G. I. (2007) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19.4.391 · Cited by 21
Triple reuptake inhibitors: Design, synthesis and structure–activity relationship of benzylpiperidine–tetrazoles
Paudel, S., Min, X., Acharya, S., Khadka, D. B., Yoon, G., Kim, K., & Cheon, S. H. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.07.046 · Cited by 21
Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor
Zoons, E., Booij, J., Delnooz, C. C. S., Dijk, J. M., Dreissen, Y. E. M., Koelman, J. H. T. M., der Salm, S. M. A. V., Škorvánek, M., Smit, M., Aramideh, M., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317352 · Cited by 21
Plasma Catecholamine Levels after Fluoxetine Treatment in Depressive Patients
Blardi, P., Lalla, A. D., Auteri, A., Iapichino, S., Dell’Erba, A., & Castrogiovanni, P. (2005) · Neuropsychobiology · doi:10.1159/000084163 · Cited by 22
Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm
Miyamoto, J., Tsuji, M., Takeda, H., Ohzeki, M., Nawa, H., & Matsumiya, T. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.043 · Cited by 21
Role of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and psychedelics in the treatment of major depressive disorder: A perspective on mechanistic insight and current status
Singh, N., Hazari, P. P., Mittal, P., Yadav, S. K., Kumar, N., Mishra, G., Dahiya, S., & Mishra, A. K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177737 · Cited by 24
Mice deficient for wild-type p53-induced phosphatase 1 display elevated anxiety- and depression-like behaviors
Ruan, C. S., Zhou, F. H., He, Z. Y., Wang, S., Yang, C., Shen, Y., Guo, Y., Zhao, H., Chen, L., Liu, D., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.037 · Cited by 22
Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression
Zhang, C., Wang, L., Xu, Y., Huang, Y., Huang, J., Zhu, J., Wang, W., Li, W., Sun, A., Li, X., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114347 · Cited by 20
Polygonum sibiricum polysaccharides alleviate chronic unpredictable mild stress-induced depressive-like behaviors by regulating the gut microbiota composition and SCFAs levels
Zhang, Y., Sun, Y., Liu, Y., Liu, J., Sun, J., Bai, Y., Fan, B., Lu, C., & Wang, F. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105411 · Cited by 20
The effects of intermittent theta burst stimulation (iTBS) on resting-state brain entropy (BEN)
Liu, P., Song, D., Deng, X., Shang, Y., Ge, Q., Wang, Z., & Zhang, H. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00556 · Cited by 19
The Effects of Pretreatment versus De Novo Treatment with Selective Serotonin Reuptake Inhibitors on Short-term Outcome after Acute Ischemic Stroke
Siepmann, T., Kepplinger, J., Zerna, C., Schatz, U., Penzlin, A. I., Pallesen, L., Illigens, B. M. W., Weidner, K., Reichmann, H., Puetz, V., et al. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.04.033 · Cited by 19
8-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors—Part II
Bromidge, S. M., Bertani, B., Borriello, M., Bozzoli, A., Faedo, S., Gianotti, M., Gordon, L. J., Hill, M., Zucchelli, V., Watson, J. M., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.056 · Cited by 20
The effects of oral taurine administration on behavior and hippocampal signal transduction in rats
Iio, W., Matsukawa, N., Tsukahara, T., & Toyoda, A. (2012) · Amino Acids · doi:10.1007/s00726-012-1282-2 · Cited by 21
Strain differences in ‘compulsive’ lever-pressing
Brimberg, L., Flaisher-Grinberg, S., Schilman, E. A., & Joel, D. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.014 · Cited by 20
Animal Models of Obsessive–Compulsive Disorder: From Bench to Bedside via Endophenotypes and Biomarkers
Joel, D., Stein, D. J., & Schreiber, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00006-0 · Cited by 20
Neuroligin modulates the locomotory dopaminergic and serotonergic neuronal pathways of C. elegans
Izquierdo, P. G., Calahorro, F., & Ruiz‐Rubio, M. (2013) · Neurogenetics · doi:10.1007/s10048-013-0377-6 · Cited by 20
Effects of Treadmill Training Combined with Serotonergic Interventions on Spasticity after Contusive Spinal Cord Injury
Ryu, Y., Ogata, T., Nagao, M., Sawada, Y., Nishimura, R., & Fujita, N. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5400 · Cited by 19
Deficiency of the ywhaz gene, involved in neurodevelopmental disorders, alters brain activity and behaviour in zebrafish
Antón-Galindo, E., Vecchia, E. D., Orlandi, J. G., Castro‐Olvera, G., Gualda, E. J., Young, A. M. J., Guasch-Piqueras, M., Arenas, C., Herrera-Úbeda, C., García‐Fernàndez, J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01577-9 · Cited by 19
Altered Gray Matter Volumes and Plasma IL-6 Level in Major Depressive Disorder Patients with Suicidal Ideation
Guo, Y., Jiang, X., Jia, L., Zhu, Y., Han, X., Wu, Y., Liu, W., Zhao, W., Zhu, H., Wang, D., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103403 · Cited by 18
DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats
Ahn, G. J., Kang, K. K., Kim, D. S., Ahn, B. O., Kim, W. B., Kang, S. K., Lee, B. C., & Hwang, W. S. (2005) · Urology · doi:10.1016/j.urology.2004.09.023 · Cited by 18
5‐HT2 receptors and anxiety
Bourin, M., & Dhonnchadha, B. Á. N. (2005) · Drug Development Research · doi:10.1002/ddr.20016 · Cited by 18
Assessing the effects of environmentally relevant concentrations of antidepressant mixtures to fathead minnows exposed over a full life cycle
Parrott, J. L., & Metcalfe, C. D. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.08.237 · Cited by 17
Does the Loudness Dependence of Auditory Evoked Potential Predict Response to Selective Serotonin Reuptake Inhibitors?: A Meta-analysis
Yoon, S., Kim, Y., & Lee, S. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.2.254 · Cited by 17
Nitrogen‐containing heterocyclic compounds: A ray of hope in depression?
Choudhary, D., Kumar, B., & Kaur, R. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14479 · Cited by 17
Hypophagia and induction of serotonin transporter gene expression in raphe nuclei of male and female rats after short-term fluoxetine treatment
Lauzurica, N., García‐García, L., Fuentes, J. A., & Delgado, M. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0188-5 · Cited by 17

Authors: Vaswani, M., Linda, F. K., & Ramesh, S.
Affiliations: All India Institute of Medical Sciences (IN)
Corresponding author: Vaswani, Meera
Venue: Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher: Elsevier BV
Published: 2003-02
Volume: 27
Issue: 1
Pages: 85-102
ISSN: 0278-5846 (ISSN-L)
DOI: 10.1016/s0278-5846(02)00338-x
OpenAlex: W1988612597
Cited by: 612
References: 203
Citations by year: 2026: 16 · 2025: 17 · 2024: 20 · 2023: 30 · 2022: 19 · 2021: 30 · 2020: 10 · 2019: 22 · 2018: 28 · 2017: 27 · 2016: 23 · 2015: 37 · 2014: 24 · 2013: 29 · 2012: 27
FWCI: 3.58
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: selective serotonin reuptake inhibitors, serotonin, serotonin receptors, antidepressant mechanism, adverse drug reactions, drug-drug interactions, cytochrome P450, therapeutic drug monitoring, tricyclic antidepressants, depression, obsessive-compulsive disorder, social anxiety disorder, anorexia nervosa, bulimia nervosa, eating disorders, sleep disorders
MeSH terms: Adolescent, Adult, Age Factors, Aged, Anxiety Disorders, Feeding and Eating Disorders, Child, Depressive Disorder, Female, Humans, Male, Middle Aged, Pregnancy, Pregnancy Complications, Substance Withdrawal Syndrome, Suicide, Attempted, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks